VBND
🇦🇺 ASX
NULL GLOBAL
NULL HEDGED
NULL INCOME
👑 Overview
📈 Performance
📙 Holdings
💰 Distributions
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💰
1.57%
Annual distribution yield
Based on the most recent distribution
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
70
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
VBND.AX was created on 2017-10-10 by Vanguard. The fund's investment portfolio concentrates primarily on investment grade fixed income. Vanguard Global Aggregate Bond Index (Hedged) ETF seeks to track the return of the Bloomberg Barclays Global Aggregate Float-Adjusted and Scaled Index hedged into Australian dollars before taking into account fees, expenses and tax
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
United States Treasury Note/Bond 4.5 2024-11-30
0.77%
United States Treasury Note/Bond 4.25 2024-12-31
0.40%
United States Treasury Note/Bond 1.25 2026-11-30
0.33%
Bundesobligation
0.32%
United States Treasury Note/Bond 3.875 2029-09-30
0.32%
United Kingdom Gilt 0.25 2025-01-31
0.30%
United States Treasury Note/Bond 2.625 2029-07-31
0.30%
United States Treasury Note/Bond 4.375 2024-10-31
0.27%
United States Treasury Note/Bond 1.75 2025-03-15
0.25%
United States Treasury Note/Bond 4.625 2025-02-28
0.23%
Updated as of 30 April 2023
Country Exposure
🇺🇸 United States of America (the)
50%
Other
10%
🇯🇵 Japan
7%
🇫🇷 France
6%
🇩🇪 Germany
4%
🇮🇹 Italy
3%
🇨🇦 Canada
3%
🇪🇸 Spain
3%
🇬🇧 United Kingdom of Great Britain and Northern Ireland (the)
2%
🇦🇺 Australia
2%
🇰🇷 Korea (the Republic of)
1%
🇧🇪 Belgium
1%
🇨🇭 Switzerland
1%
🇳🇱 Netherlands (the)
1%
🇮🇩 Indonesia
1%
🇦🇹 Austria
1%
🇨🇳 China
1%
💰 Distributions
Payouts
💰 Annual Distribution Yield*
1.57%
💰 Annual Distribution Earnings Per $1,000 invested**
$15.69
💰 Most Recent Distribution Franked Percentage Estimate
0.00%
💰 Average Distribution Franked Percentage Estimate
0.00 %
💰 Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.36
0.00%
2022
$0.63
0.00%
2021
$4.15
0.00%
2020
$2.42
0.00%
2019
$1.10
0.00%
2018
$0.64
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
💵 Costs
💼
0.20%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$40.91
💰 Price To Earnings Ratio
0.00
💰 Price To Book Ratio
0.00
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in VBND
70
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in VBND
679 days
VBND investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
11%
50k - 100k
49%
Less than 50k
24%
👶 Age of investors
18 - 25
26 - 34
49%
35 - 90
44%
🙋 Legal gender of investors
Female
51%
Male
49%
Pearlers who invest in VBND also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
📊 Share price
$104.08 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
VGE.AX was created on 2013-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Seeks to track the return of the FTSE Emerging Markets All Cap China A Inclusion Index in Australian dollars, before taking into account fees, expenses and tax.
📊 Share price
$67.24 AUD
NULL OTHER
NULL EX AUSTRALIA
NULL EMERGING
NULL BETA
VISM.AX was created on 2018-10-24 by Vanguard. The fund's investment portfolio concentrates primarily on small cap equity. The Vanguard MSCI International Small Companies Index ETF seeks to track the return of the MSCI World ex-Australia Small Cap Index in Australian dollars, before taking into account fees, expenses and tax.
📊 Share price
$56.38 AUD
NULL GLOBAL
NULL EX AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
Want more shares? Try these...
Vectus Biosystems Ltd. operates as a drug discovery and development company. The company is headquartered in Rosebery, New South Wales. The company went IPO on 2016-02-23. The firm focuses on medical research and development. The company is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. The company also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The firm has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.
📊 Share price
$0.50 AUD
VBLD.AX was created on 2018-10-19 by Vanguard. The fund's investment portfolio concentrates primarily on theme equity. Vanguard Global Infrastructure Index ETF seeks to track the return of the FTSE Developed Core Infrastructure Index (with net dividends reinvested) in Australian dollars, before taking into account fees, expenses and tax.
📊 Share price